{"symbol": "TYME", "companyName": "Tyme Technologies Inc.", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.tymeinc.com", "description": "Tyme Technologies Inc is a clinical-stage pharmaceutical company focused on discovering and developing targeted cancer therapeutics for a broad range of oncology indications. The Company is developing proprietary combination drug product.", "CEO": "Steve Hoffman", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}